Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands.
about
Tea, coffee, and caffeine and early-onset basal cell carcinoma in a case-control study.Nonablative fractional laser resurfacing for the treatment of scars and grafts after Mohs micrographic surgery: a randomized controlled trial.Skin lesions suspected of malignancy: an increasing burden on general practice.In vivo confocal microscopy of basal cell carcinoma: a systematic review of diagnostic accuracy.Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinomaIndoor tanning and risk of early-onset basal cell carcinoma.MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project.Assessment of clinical diagnostic accuracy compared with pathological diagnosis of basal cell carcinoma.Pattern of HPV infection in basal cell carcinoma and in perilesional skin biopsies from immunocompetent patients.In vivo assessment of optical properties of basal cell carcinoma and differentiation of BCC subtypes by high-definition optical coherence tomographyA clinicopathological survey of Basal cell carcinoma in an Iranian population.Diagnosis of Basal Cell Carcinoma by Reflectance Confocal Microscopy: Study Design and Protocol of a Randomized Controlled Multicenter TrialIs early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening.Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2/M phase arrest.The current and future role of general practitioners in skin cancer care: an assessment of 268 general practitioners.One-stop-shop with confocal microscopy imaging vs. standard care for surgical treatment of basal cell carcinoma: an open-label, noninferiority, randomized controlled multicentre trial.Skin disorders in elderly subjects.Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial.A national study on adherence to a basal cell carcinoma guideline; development of a tool to assess guideline adherence.High-definition optical coherence tomography algorithm for discrimination of basal cell carcinoma from clinical BCC imitators and differentiation between common subtypes.Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.Frequency of non-histologically diagnosed basal cell carcinomas in daily Dutch practice.Predictors of tanning dependence in white non-Hispanic females and males.Morphology of basal cell carcinoma in high definition optical coherence tomography: en-face and slice imaging mode, and comparison with histology.Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma.Imaging of basal cell carcinoma by high-definition optical coherence tomography: histomorphological correlation. A pilot study.Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions.Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010-2050.Mohs micrographic surgery for basal cell carcinomas: appropriateness of 'Rotterdam' criteria and predictive factors for three or more stages.Ex vivo high-definition optical coherence tomography of basal cell carcinoma compared to frozen-section histology in micrographic surgery: a pilot study.Potential impact of self-perceived prodromal symptoms on the early diagnosis of Parkinson's disease.Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype.Body mass index, height and early-onset basal cell carcinoma in a case-control study.
P2860
Q33762312-4A545555-8663-4E63-8E12-7DB8EA9F52A5Q34324427-D3D51145-942B-4630-AF32-3FE6056D4488Q35091952-62A5C9C1-11F0-496F-A2E3-C77A22FCB2B7Q35750933-B9CD3B34-DA17-41AC-A522-2DE57BF5E9C7Q35834723-22A33E9C-3204-4582-A779-1022F7EF273DQ35840159-30404C13-D3D1-4D18-A202-4800950345EEQ35863179-195B6926-1AD1-492F-AC9C-2A6C847E36F0Q35884708-0A936DB7-9009-468D-A57A-9165333B6873Q36535894-DC1EFD6F-889B-4F04-8515-B7FB7016D218Q37032346-E36E56D0-365D-4906-B4F1-266D60672D18Q37688101-5D291AE4-AAE3-4EDB-A649-C10125029CC4Q38379473-888FEB46-A989-40ED-813E-B35826CD9576Q38731383-C2EAB2D9-4204-42C7-9461-54AD96F6ADF3Q38947243-C20FA6F9-C00D-4FD0-94DC-BAA6B9B697EBQ39237377-64FC36B4-DC41-4AAD-8B87-6BD5D689E09EQ40251693-DCFD8D81-BC57-4C41-880D-1041ECDA7794Q41120711-80A9004F-3007-4767-9BAB-CAB65436245CQ42463001-92DEB919-E6C5-4883-ADF8-6645B62B1C69Q42463957-759C0812-4353-4D28-B8F2-9EF959268403Q42473344-D07A8C0E-DD23-476D-9D9E-1D38AC6500E6Q42490689-51AA9CAD-348E-4E68-A7FE-127EE967029EQ42499766-6353FEF7-77CB-43A9-8864-B8B0FBA7D05DQ42504828-027D21BA-3C4E-45C9-8F65-9484245C1B57Q42505523-0C7D1DEC-A3AC-477D-99FD-9D63AF8B4FEFQ42507858-B6D6F07C-B33E-419A-9BBE-28F3CB7CD731Q42510706-1BE99001-2B67-48F5-9E73-67342CFC8701Q42510985-2A24F964-32D2-49F8-8A75-0D9B4B4839E7Q42510997-2B1554BD-5058-4C9F-9CE8-8EC1E38D624CQ42513765-8265F814-C176-4BF3-8A4C-6451BBBF7CD8Q42518531-FF7402AC-0DE8-476E-8AF9-5C685C208C1DQ45337355-1AC3FAA8-5D08-4AEC-8AF7-D85CE07A886AQ45914002-0570C1EE-BFFF-47AD-90B6-2F1879A7E1AAQ50440960-65D55A27-4FEA-4BFE-BA4D-96FFB64F0F7BQ53600348-0389A06A-ED3C-4496-85B2-92E049BDA329
P2860
Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Incidence, prevalence and futu ...... carcinoma in the Netherlands.
@en
Incidence, prevalence and futu ...... carcinoma in the Netherlands.
@nl
type
label
Incidence, prevalence and futu ...... carcinoma in the Netherlands.
@en
Incidence, prevalence and futu ...... carcinoma in the Netherlands.
@nl
prefLabel
Incidence, prevalence and futu ...... carcinoma in the Netherlands.
@en
Incidence, prevalence and futu ...... carcinoma in the Netherlands.
@nl
P2093
P356
P1476
Incidence, prevalence and futu ...... carcinoma in the Netherlands.
@en
P2093
H A Martino Neumann
Jan-Willem W Coebergh
Sophie C Flohil
Tamar Nijsten
P356
10.2340/00015555-1009
P577
2011-01-01T00:00:00Z